EyePoint (EYPT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.99, -4.78% vs the prior close of $3.14.
- Volume 2.75M shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
EYPT slides 4.8% to $2.99, a 52-week low. Closed at $2.99, -4.78% vs the prior close of $3.14. Day range $2.95–$3.15, opened at $3.14.
EYPT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — EYPT slides 4.8% to $2.99, a 52-week low
- Closed at $2.99, -4.78% vs the prior close of $3.14. Day range $2.95–$3.15, opened at $3.14.
- Volume was 2.75M shares, 0.6x its 50-day average of 4.72M — lighter than usual.
- Price is -42.6% vs its 50-day average ($5.21) and -74.7% vs its 200-day average ($11.81).
- 52-week range $2.93–$19.11; today's close sits at 0% of that range, 84.4% below the 52-week high.
Oct 15, 2026 — EYPT jumps 4.3% to $3.14
- Closed at $3.14, +4.32% vs the prior close of $3.01. Day range $3.01–$3.18, opened at $3.02.
- Volume was 2.84M shares, 0.6x its 50-day average of 4.71M.
- Price is -41.9% vs its 50-day average ($5.40) and -73.6% vs its 200-day average ($11.88).
- 52-week range $2.93–$19.11; today's close sits at 1% of that range, 83.6% below the 52-week high.
Oct 14, 2026 — EYPT dips 2.0% to $3.01, a 52-week low, 4 down days in a row
- Closed at $3.01, -1.95% vs the prior close of $3.07. Day range $2.93–$3.06, opened at $3.04.
- Volume was 3.16M shares, 0.7x its 50-day average of 4.71M.
- Price is -46.1% vs its 50-day average ($5.58) and -74.8% vs its 200-day average ($11.96).
- 52-week range $2.93–$19.11; today's close sits at 0% of that range, 84.2% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — EYPT slides 7.5% to $3.07, a 52-week low, 3 down days in a row
- Closed at $3.07, -7.53% vs the prior close of $3.32. Day range $3.06–$3.32, opened at $3.30.
- Volume was 2.51M shares, 0.5x its 50-day average of 4.69M — lighter than usual.
- Price is -46.7% vs its 50-day average ($5.76) and -74.5% vs its 200-day average ($12.03).
- 52-week range $3.05–$19.11; today's close sits at 0% of that range, 83.9% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — EYPT dips 2.4% to $3.32
- Closed at $3.32, -2.35% vs the prior close of $3.40. Day range $3.29–$3.43, opened at $3.42.
- Volume was 1.90M shares, 0.4x its 50-day average of 4.68M — lighter than usual.
- Price is -44.2% vs its 50-day average ($5.95) and -72.6% vs its 200-day average ($12.11).
- 52-week range $3.05–$19.11; today's close sits at 2% of that range, 82.6% below the 52-week high.
Oct 9, 2026 — EYPT dips 1.7% to $3.40
- Closed at $3.40, -1.73% vs the prior close of $3.46. Day range $3.38–$3.57, opened at $3.44.
- Volume was 1.94M shares, 0.4x its 50-day average of 4.67M — lighter than usual.
- Price is -44.5% vs its 50-day average ($6.12) and -72.1% vs its 200-day average ($12.18).
- 52-week range $3.05–$19.11; today's close sits at 2% of that range, 82.2% below the 52-week high.
Oct 8, 2026 — EYPT jumps 4.2% to $3.46, 3 up days in a row
- Closed at $3.46, +4.22% vs the prior close of $3.32. Day range $3.27–$3.52, opened at $3.30.
- Volume was 3.26M shares, 0.7x its 50-day average of 4.65M.
- Price is -45.2% vs its 50-day average ($6.31) and -71.8% vs its 200-day average ($12.26).
- 52-week range $3.05–$19.11; today's close sits at 3% of that range, 81.9% below the 52-week high.
- That makes 3 straight gains.
Oct 7, 2026 — EYPT jumps 4.7% to $3.32
- Closed at $3.32, +4.73% vs the prior close of $3.17. Day range $3.08–$3.42, opened at $3.15.
- Volume was 3.02M shares, 0.7x its 50-day average of 4.62M.
- Price is -48.8% vs its 50-day average ($6.48) and -73.1% vs its 200-day average ($12.33).
- 52-week range $3.05–$19.11; today's close sits at 2% of that range, 82.6% below the 52-week high.
Oct 6, 2026 — EYPT rises 0.6% to $3.17
- Closed at $3.17, +0.63% vs the prior close of $3.15. Day range $3.08–$3.29, opened at $3.18.
- Volume was 1.98M shares, 0.4x its 50-day average of 4.61M — lighter than usual.
- Price is -52.4% vs its 50-day average ($6.66) and -74.4% vs its 200-day average ($12.40).
- 52-week range $3.05–$19.11; today's close sits at 1% of that range, 83.4% below the 52-week high.
Oct 5, 2026 — EYPT slides 3.1% to $3.15, a 52-week low
- Closed at $3.15, -3.08% vs the prior close of $3.25. Day range $3.05–$3.28, opened at $3.28.
- Volume was 2.76M shares, 0.6x its 50-day average of 4.59M.
- Price is -53.9% vs its 50-day average ($6.84) and -74.7% vs its 200-day average ($12.47).
- 52-week range $3.05–$19.11; today's close sits at 1% of that range, 83.5% below the 52-week high.
Oct 2, 2026 — EYPT rises 0.6% to $3.25
- Closed at $3.25, +0.62% vs the prior close of $3.23. Day range $3.10–$3.31, opened at $3.31.
- Volume was 3.11M shares, 0.7x its 50-day average of 4.55M.
- Price is -53.7% vs its 50-day average ($7.02) and -74.1% vs its 200-day average ($12.54).
- 52-week range $3.10–$19.11; today's close sits at 1% of that range, 83.0% below the 52-week high.
EYPT latest news & SEC filings
Every SEC filing by or about EYPT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 8, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Zaderej Karen L. bought 10,600 shares at $4.93 (≈$52.26K) on Aug 18, 2026
- Zaderej Karen L. bought 10,600 shares at $4.93 (≈$52.26K) on Aug 18, 2026
- Zaderej Karen L. bought 10,600 shares at $4.93 (≈$52.26K) on Aug 18, 2026
- Zaderej Karen L. bought 10,600 shares at $4.93 (≈$52.26K) on Aug 18, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $507.00K (prior year $5.33M) (-90.5% vs Jun 30, 2025)
- Net income: -$94.47M (prior year -$59.43M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.09 (prior year -$0.85) (loss widened vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 28, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade EYPT
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Mar 4, 2026, Jan 7, 2026. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.52% (largest 8.6%). That is a volatile stock.
- Liquidity: about 2.81M shares (≈$8.41M) trade per day on average.
- 52-week position: $2.99 vs a range of $2.93–$19.11 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 17 sales; latest: Karen L. Zaderej bought 10,600 shares on Aug 18, 2026.
- Latest filings: 8-K Sep 10, 2026; 8-K Aug 17, 2026; 10-Q Aug 5, 2026.
- Share count: 86.21M shares outstanding (Jul 31, 2026), +25.1% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Laboratory Analytical Instruments.
EYPT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.14 | 3.15 | 2.95 | 2.99 | 2.75M |
| Oct 15, 2026 | 3.02 | 3.18 | 3.01 | 3.14 | 2.84M |
| Oct 14, 2026 | 3.04 | 3.06 | 2.93 | 3.01 | 3.16M |
| Oct 13, 2026 | 3.30 | 3.32 | 3.06 | 3.07 | 2.51M |
| Oct 12, 2026 | 3.42 | 3.43 | 3.29 | 3.32 | 1.90M |
| Oct 9, 2026 | 3.44 | 3.57 | 3.38 | 3.40 | 1.94M |
| Oct 8, 2026 | 3.30 | 3.52 | 3.27 | 3.46 | 3.26M |
| Oct 7, 2026 | 3.15 | 3.42 | 3.08 | 3.32 | 3.02M |
| Oct 6, 2026 | 3.18 | 3.29 | 3.08 | 3.17 | 1.98M |
| Oct 5, 2026 | 3.28 | 3.28 | 3.05 | 3.15 | 2.76M |
| Oct 2, 2026 | 3.31 | 3.31 | 3.10 | 3.25 | 3.11M |
| Oct 1, 2026 | 3.29 | 3.45 | 3.23 | 3.23 | 2.86M |
| Sep 30, 2026 | 3.42 | 3.46 | 3.25 | 3.27 | 3.43M |
| Sep 29, 2026 | 3.31 | 3.50 | 3.30 | 3.42 | 2.54M |
| Sep 28, 2026 | 3.58 | 3.60 | 3.27 | 3.31 | 3.30M |
| Sep 25, 2026 | 3.65 | 3.71 | 3.56 | 3.62 | 2.25M |
| Sep 24, 2026 | 3.71 | 3.73 | 3.54 | 3.65 | 2.30M |
| Sep 23, 2026 | 4.10 | 4.18 | 3.71 | 3.72 | 2.02M |
| Sep 22, 2026 | 4.08 | 4.22 | 3.97 | 4.07 | 4.46M |
| Sep 21, 2026 | 3.87 | 4.10 | 3.80 | 4.02 | 3.86M |
About EyePoint
EyePoint (EYPT) is listed on the Nasdaq and classified by the SEC under “Laboratory Analytical Instruments”. Its business address is in WATERTOWN, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1314102.
EYPT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Goran Ando | Director | Jan 6, 2026 |
| Wendy F Dicicco | Director | Jan 6, 2026 |
| Jay S. Duker | President and CEO | Jul 14, 2026 |
| Stuart Duty | Director | Jan 6, 2026 |
| Fred Hassan | Director | Jan 6, 2026 |
| John B. Landis | Director | Jan 6, 2026 |
| Nancy Lurker | Director | Jan 7, 2026 |
| Reginald J. Sanders | Director | Jan 6, 2026 |
| Karen L. Zaderej | Director | Aug 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jay S. Duker | President and CEO | Jul 14, 2026 |
| George Elston | Chief Financial Officer | Aug 24, 2026 |
| Ramiro Ribeiro | Chief Medical Officer | Jul 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 18, 2026 | Karen L. Zaderej | Buy | 10,600 | $4.93 |
| Aug 18, 2026 | Karen L. Zaderej | Buy | 10,600 | $4.93 |
| Aug 18, 2026 | Karen L. Zaderej | Buy | 10,600 | $4.93 |
| Aug 18, 2026 | Karen L. Zaderej | Buy | 10,600 | $4.93 |
| Jun 30, 2026 | Ramiro Ribeiro | Sale | 2,438 | $15.02 |
| Jun 30, 2026 | Ramiro Ribeiro | Sale | 2,437 | $15.00 |
| Jun 30, 2026 | Ramiro Ribeiro | Sale | 2,438 | $15.02 |
| Jun 30, 2026 | Ramiro Ribeiro | Sale | 2,437 | $15.00 |
| Jun 30, 2026 | Ramiro Ribeiro | Sale | 2,438 | $15.02 |
| Jun 30, 2026 | Ramiro Ribeiro | Sale | 2,437 | $15.00 |
| Jun 30, 2026 | Ramiro Ribeiro | Sale | 2,438 | $15.02 |
| Jun 30, 2026 | Ramiro Ribeiro | Sale | 2,437 | $15.00 |
| Apr 17, 2026 | Ramiro Ribeiro | Sale | 2,437 | $15.00 |
| Apr 17, 2026 | Ramiro Ribeiro | Sale | 2,437 | $15.00 |
| Apr 17, 2026 | Ramiro Ribeiro | Sale | 2,437 | $15.00 |
EYPT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $31.37M | $-231.96M | -3.17 | $-240.11M |
| Dec 31, 2024 | $43.27M | $-130.87M | -2.32 | $-126.23M |
| Dec 31, 2023 | $46.02M | $-70.80M | -1.82 | $1.88M |
| Dec 31, 2022 | $41.40M | $-102.25M | -2.74 | $-65.00M |
| Dec 31, 2021 | $36.94M | $-58.42M | -2.03 | $-50.10M |
Latest balance sheet: total assets $228.19M, total liabilities $61.78M, cash $110.46M (as of Jun 30, 2026).
EYPT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $12.25 |
| May 6, 2026 | 8-K Item 2.02 (results) | $13.35 |
| Mar 4, 2026 | 8-K Item 2.02 (results) | $18.00 |
| Jan 7, 2026 | 8-K Item 2.02 (results) | $17.37 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $11.02 |
| Oct 14, 2025 | 8-K Item 2.02 (results) | $13.16 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $10.58 |
| May 7, 2025 | 8-K Item 2.02 (results) | $6.09 |
| Mar 5, 2025 | 8-K Item 2.02 (results) | $6.58 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $7.75 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $11.59 |
| Oct 28, 2024 | 8-K Item 2.02 (results) | $12.12 |
Related stocks · Laboratory Analytical Instruments
Illumina (ILMN)Agilent Technologies (A)Waters (WAT)10x Genomics (TXG)Mettler Toledo International Inc/ (MTD)Revvity (RVTY)Avantor (AVTR)Bruker (BRKR)Bio-Rad Laboratories (BIO)Pacific Biosciences Of California (PACB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on EYPT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.